ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04621	NOD-like receptor signaling pathway	26/178	157/7206	5.6568446748e-15
ko04064	NF-kappa B signaling pathway	19/178	96/7206	1.19291617246e-12
ko04217	Necroptosis	22/178	178/7206	3.19756489278e-10
ko04620	Toll-like receptor signaling pathway	15/178	100/7206	1.75086165649e-08
ko04668	TNF signaling pathway	16/178	120/7206	3.24027170899e-08
ko05164	Influenza A	18/178	167/7206	1.24804165823e-07
ko04380	Osteoclast differentiation	16/178	134/7206	1.5698041655e-07
ko05168	Herpes simplex infection	17/178	182/7206	2.17972279392e-06
ko05152	Tuberculosis	17/178	187/7206	3.16899540394e-06
ko05167	Kaposi's sarcoma-associated herpesvirus infection	17/178	191/7206	4.23408107518e-06
ko05160	Hepatitis C	15/178	153/7206	4.89052439246e-06
ko05161	Hepatitis B	16/178	173/7206	5.01179417456e-06
ko05162	Measles	13/178	120/7206	7.19216046335e-06
ko04060	Cytokine-cytokine receptor interaction	16/178	191/7206	1.77545301312e-05
ko04622	RIG-I-like receptor signaling pathway	9/178	62/7206	1.83805961547e-05
ko04142	Lysosome	14/178	151/7206	1.94761425471e-05
ko04210	Apoptosis	15/178	180/7206	3.48932544257e-05
ko04623	Cytosolic DNA-sensing pathway	7/178	41/7206	5.512660409e-05
ko04660	T cell receptor signaling pathway	11/178	124/7206	0.000230059932185
ko05145	Toxoplasmosis	11/178	126/7206	0.000264826832313
ko04662	B cell receptor signaling pathway	9/178	88/7206	0.00029840008497
ko05321	Inflammatory bowel disease (IBD)	7/178	56/7206	0.000416314712169
ko05340	Primary immunodeficiency	5/178	30/7206	0.000750202728096
ko05140	Leishmaniasis	7/178	75/7206	0.00240505006551
ko05131	Shigellosis	7/178	82/7206	0.00398809472796
ko05142	Chagas disease (American trypanosomiasis)	9/178	130/7206	0.00474779916428
ko05144	Malaria	5/178	45/7206	0.00477262368165
ko05169	Epstein-Barr virus infection	12/178	206/7206	0.00487694569363
ko04630	Jak-STAT signaling pathway	9/178	132/7206	0.0052464197804
ko00512	Mucin type O-glycan biosynthesis	4/178	29/7206	0.00527468278494
ko04657	IL-17 signaling pathway	7/178	87/7206	0.0055310538361
ko04624	Toll and Imd signaling pathway	5/178	49/7206	0.00688230900796
ko05100	Bacterial invasion of epithelial cells	7/178	99/7206	0.0110194094456
ko04612	Antigen processing and presentation	6/178	77/7206	0.0116260776061
ko04672	Intestinal immune network for IgA production	4/178	37/7206	0.0125901449873
ko00531	Glycosaminoglycan degradation	3/178	23/7206	0.0182503229137
ko00600	Sphingolipid metabolism	5/178	63/7206	0.0192619620452
ko05221	Acute myeloid leukemia	5/178	63/7206	0.0192619620452
ko05215	Prostate cancer	7/178	111/7206	0.0196816291289
ko05330	Allograft rejection	3/178	24/7206	0.0204864357907
ko00511	Other glycan degradation	3/178	26/7206	0.0253902586855
ko05120	Epithelial cell signaling in Helicobacter pylori infection	6/178	92/7206	0.0258875256232
ko04215	Apoptosis - multiple species	4/178	47/7206	0.0281347045541
ko04658	Th1 and Th2 cell differentiation	6/178	96/7206	0.0310756183452
ko04214	Apoptosis - fly	5/178	72/7206	0.0321647201117
ko04650	Natural killer cell mediated cytotoxicity	6/178	97/7206	0.0324714265454
ko05320	Autoimmune thyroid disease	3/178	29/7206	0.0338216659654
ko05132	Salmonella infection	6/178	98/7206	0.033907487362
ko05146	Amoebiasis	6/178	99/7206	0.0353841375504
ko01523	Antifolate resistance	3/178	30/7206	0.0369162114461
ko00590	Arachidonic acid metabolism	4/178	52/7206	0.0388697656626
ko01524	Platinum drug resistance	5/178	76/7206	0.0392947952044
ko05418	Fluid shear stress and atherosclerosis	9/178	173/7206	0.0397489196607
ko05130	Pathogenic Escherichia coli infection	5/178	77/7206	0.0412162339266
ko04664	Fc epsilon RI signaling pathway	5/178	77/7206	0.0412162339266
ko05143	African trypanosomiasis	3/178	32/7206	0.0435244148313
ko04659	Th17 cell differentiation	6/178	106/7206	0.0468814565836
ko05203	Viral carcinogenesis	12/178	277/7206	0.0482625440876